SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-032234
Filing Date
2021-12-22
Accepted
2021-12-22 08:00:40
Documents
15
Period of Report
2021-12-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 32801
2 ex99-1.htm EX-99.1 15700
3 form8-k_001.jpg GRAPHIC 5336
4 ex99-1_001.jpg GRAPHIC 5735
  Complete submission text file 0001493152-21-032234.txt   248446

Data Files

Seq Description Document Type Size
5 lpcn-20211222.xsd EX-101.SCH 3025
6 lpcn-20211222_lab.xml EX-101.LAB 34240
7 lpcn-20211222_pre.xml EX-101.PRE 22359
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3605
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 211511020
SIC: 2834 Pharmaceutical Preparations